Huakang Biomedical Holdings Company Limited (08622)

Directors Auditors

Director	From	To	Position(s)	Release Date / Document Links	Reason for Change
Bu Su	08-Aug-24		NED
Chan Peter Kin Sang	26-Nov-18	02-Apr-24	INED
Chang Yim Yang			Sen Mgr
Chau Lai Ki	31-Aug-26		CFO
	07-Nov-17		CoSec
	07-Nov-17	31-Aug-26	FC	31-Aug-26	Re-designated from a Financial Controller of the Company to the Chief Financial Officer of the Company.
Cheng Gary Faat Ting	31-Aug-26		INED, ChAC
	01-Sep-20	08-Jul-25	INED	08-Jul-25	Dr. Cheng intended to devote more time to his other business and personal commitments.
		08-Jul-25	ChCC	08-Jul-25	Dr. Cheng intended to devote more time to his other business and personal commitments.
Chow Ching Man	02-Aug-23	22-Jan-25	INED	22-Jan-25	Ms. Chow intended to devote more time to her other personal business and commitments.
Chow Ching Man		22-Jan-25	MbAC, MbNC	22-Jan-25	Ms. Chow intended to devote more time to her other personal business and commitments.
Chow Joseph Kwok Fai	16-Dec-20		INED
He Jiaming	14-Jan-20	16-Apr-25	ED	16-Apr-25	After discussion with the Board, Mr. He intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions.
Kwok Wilson Chi Shing	26-Nov-18	01-Sep-20	INED
Poon Michael Lai Yin	31-Aug-26		CEO
	03-Aug-17		ED
	03-Aug-17	31-Aug-26	CFO	31-Aug-26	Re-designated from the Chief Financial Officer to the Chief Executive Officer of the Company.
Shih Mei Ling	03-Dec-24	28-Feb-25	INED	28-Feb-25	Ms. Shih resigned as she intended to devote more time to her other personal business and commitments.
Tsui Wing Tak	22-Jan-25	31-Aug-26	INED	31-Aug-26	He intended to devote more time to his other personal business and commitments.
	08-Jul-25	31-Aug-26	ChAC	31-Aug-26	He intended to devote more time to his other personal business and commitments.
		31-Aug-26	MbNC	31-Aug-26	He intended to devote more time to his other personal business and commitments.
Xu Ming	25-Oct-24	30-Mar-26	NED	30-Mar-26	Resigned to devote more time to his other personal business and commitments.
Yeung David Wai Chow	26-Nov-18	16-Dec-20	INED
Zhang Chunguang	03-Aug-17		ED
	03-Aug-17	31-Aug-26	CEO	31-Aug-26	He intended to devote more time to focus on the management of the business of Shenzhen Huakang Bio-Medical Engineering Limited* (深圳華康生物醫學工程有限公司), which is an indirect wholly-owned subsidiary of the Company.
		31-Aug-26	MbCC	31-Aug-26	He intended to devote more time to focus on the management of the business of Shenzhen Huakang Bio-Medical Engineering Limited* (深圳華康生物醫學工程有限公司), which is an indirect wholly-owned subsidiary of the Company.
Zhang Shuguang	03-Aug-17		Ch
Zhang Shuguang		29-Aug-25	ED, AuRep	29-Aug-25	Mr. Zhang intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions.
Zhang Yujing	29-Aug-25		Ch
	29-Aug-25	31-Aug-26	AuRep, ChNC	31-Aug-26	Resigned; remains as an executive Director.
		31-Aug-26	Co-Ch	31-Aug-26	Resigned; remains as an executive Director.
Zhou Xunyong	31-Aug-26		Ch, MbCC, ChNC, AuRep
	20-Nov-25		ED
	11-Dec-25	31-Aug-26	Co-Ch	31-Aug-26	Re-designated from a Co-Chairman of the Board to the Chairman of the Board.